Human Subjects Research 101
The following pages contain a brief introduction to human subjects research, the Federal Regulations regarding human subjects research, and the review process at Brandeis University for research involving human subjects.- Brief History of the IRB
- Defining Human Subjects Research
- Kinds of Human Subjects Research
- Research Review Process
- Criteria for Review of Research
- Review Categories
- Informed Consent
- Vulnerable Subjects
- Social and Behavioral Research - focuses on individual and group behavior, mental processes, or social constructs and usually generates data by means of surveys, interviews, observations, studies of existing records, and experimental designs involving exposure to some type of stimulus or environmental intervention. The vast majority of research reviewed by the Brandeis IRB is social and behavioral research.
- Biomedical Research - seeks to increase scientific understanding about normal or abnormal physiology, disease states, or development; and to evaluate the safety, effectiveness, or usefulness of a medical product, procedures, or intervention.
- Clinical Research - involves the evaluation of biomedical or behavioral interventions related to disease processes or normal physiological functioning.
- Quality Assurance Activities - attempt to measure the effectiveness of programs of services. Such activities may constitute human subject research, and require IRB review, if they are designed or intended to contribute to generalizable knowledge. Quality assurance activities that are designed solely for internal program evaluation purposes with no external application or generalization may not necessarily require IRB review. In all cases, however, the IRB, not the individual investigator, will determine when IRB review of such activities is required.
- Pilot Studies - those that involved human subjects are considered human subject research and require IRB review.
| Start date | The date upon which researchers may begin their project, not before (please remember, there is no "retroactive" IRB approval for projects). |
| End date | The final date upon which the researcher may collect or analyze data. If the research is Exempt, there is not an end date. |
| Responsibilities | If the research project will continue beyond the end date, researchers must complete a Progress Report and Continuing Review Request 30 days prior to the end
date. (Suggestion: Mark the 30-day-prior date on your calendar and set a reminder 1 week in advance so that you don't forget!)
If a project is complete - even for exempt research - the researcher must complete a Final Report and Termination Notice. |
Additional requests | Sometimes the IRB will approve a protocol but require additional information from the researcher. Please submit this information as soon as possible so that your file will be complete. |
- Risks are minimized
Any time a researcher engages human subjects in research, some risk exists. It is never the case that "no" risk exists to participants in a research project. If you cannot foresee any risks in your research project, please state that the risks to participants are "minimal". The IRB reviews each protocol to determine if the risks to subjects are minimized. The members carefully review the research proposal to ensure procedures that are consistent with sound research design are used and that they do not expose subjects to unnecessary risks. Though the Brandeis IRB encourages freedom in research design, they do consider the research plan, including the research design and methodology to determine that there are no flaws that would place subjects at unnecessary risk. It is important to note that projects can and will contain risks, but the risks should be fully recognized with a description of how these risks will be managed in the research protocol. Since most of the research submitted to the Brandeis IRB is social and behavioral research, the following considerations will be especially helpful when writing a protocol and describing the risks involved. As always, researchers should think carefully about their research, as other risks may also be applicable to it. Some common risks are:- The potential for participants to experience stress, anxiety, guilt, or trauma that can result in genuine psychological harm
- The risk of criminal or civil liability or other risks that can result in serious social harms, such as damage to financial standing, employability, insurability, or reputation; stigmatization; and damage to social relationships.
- The risk of individually identifiable private information that you have collected being leaked, resulting in a breach of confidentiality that could harm subjects.
- Risks are reasonable relative to anticipated benefits
The IRB reviews the protocol to determine that the risks of the research are reasonable in relation to the anticipated benefits (if any) to the subjects or to society through the knowledge that may reasonably be expected to result. - Equitable selection of subjects
Each protocol is carefully reviewed by the Committee for the subject criteria and recruitment procedures involved in the research project. The Committee seeks to determine that the burdens and benefits of the research are being distributed equitably - that is, across genders, races, etc. If you seek to exclude certain populations, please justify your decision. - Informed consent procedures and documentation
The IRB will review each protocol to determine that legally effective informed consent will be sought from each prospective participant (or their legally authorized representative) and effectively documented. They will also assess the protocol for any situations that could lend themselves to the perception of coercing subjects to participate in the study. If you feel that your research qualifies for a waiver of informed consent, give a detailed explanation for your request to waive it. - Data safety and confidentiality
Each protocol must provide for monitoring of the collected data for the safety of the subjects, especially where risks to the subjects are substantial. The data safety plan should also include procedures for reporting adverse events, if any. - Privacy of subjects and confidentiality of data
Provisions must be given in each protocol for the protection of the privacy and confidentiality of subjects and information about them. The IRB will consider the nature, probability, and magnitude of harms that would be likely to result from a disclosure of collected information outside the research. It will evaluate the effectiveness of proposed anonymizing techniques, coding systems, encryption methods, storage facilities, access limitations, and other relevant factors in determining the adequacy of confidentiality protections. In discussing privacy, anonymity, and confidentiality, please keep the following definitions in mind:- Privacy refers to the interest that persons have in controlling others' access to themselves.
- Confidentiality refers to the agreement between researcher and subject about access by others to the data.
- Anonymity refers to data that include no unique identifiers such as name or Social Security number.
- Additional Safeguards for Vulnerable Subjects
If your research includes vulnerable subjects such as children, prisoners, pregnant women, persons with mental disabilities or those who are economically or educationally disadvantaged, the IRB will review your application to determine that appropriate additional safeguard have been included in the project to protect the rights and welfare of these subjects.
Researchers conducting human subject research are subject to the regulations at 45 CFR 46. These regulations provide for three categories under which human subject research is to be reviewed: Exempt, Expedited, and Full Committee Review. A list identifying and defining the research review categories can be found here.
| Exempt Research: | The regulations identify specific categories of research activities that are exempt from the regulations on the protection of human subjects in research. While a project may be exempt from the regulations, the ethical principles of conducting research with humans still apply (minimizing risk, maximizing benefit, and ensuring privacy) and all of the rights and protection afforded to human subjects in research are required in Exempt status cases. At Brandeis, researchers engaged in human subject research that qualifies for Exempt status must still complete a full application form, prepare an informed consent statement, and at the conclusion of the project, complete a Final Report and Termination Form. Investigators may not make the determination that their own research is exempt: Only the IRB can make the determination that research is exempt from IRB review. |
| Expedited Review: | Research projects that qualify for Expedited review may be reviewed and approved without convening a meeting of the entire IRB. The term "expedited" can be misleading: reviews of this type are not "quicker" or conducted with less rigor, rather fewer reviewers are required. Expedited review can be considered when research activities present no more than minimal risk to human subjects and involve only procedures listed in one or more of the nine categories identified in the regulations or for minor changes to previously approved research. Researchers are reminded that the standard requirements for informed consent (or its waiver, alteration, or exception) also apply to expedited review. |
| Full Committee Review: | Projects involving greater than minimal risk require approval by the fully convened IRB. Such projects will be reviewed at the monthly IRB meeting, the date and submission deadline of which is posted here. Some examples of Full Committee Review research includes research with children and other vulnerable populations; invasive procedures; any research involving deception; surveys involving sensitive questions, information about sexual practice or illegal behavior, or questions likely to be stressful to the subject. |
The federal regulations require that researchers obtain legally effective, documented, voluntary informed consent from prospective subjects (or subjects' legally authorized representative) before subjects can be included in research. Keep in mind that obtaining informed consent is a continuous process throughout the research, not just a one-time event when a subject signs a form. Researchers should work to communicate clearly and effectively with their participants and to build trust and cooperation with their participants. Researchers should openly and willingly explain their research and answer questions from subjects and be sensitive to the needs and concerns of their research participants.
| Informed Consent Document |
Obtaining informed consent is most often accomplished through an informed consent form that each researcher creates for the research project. Please refer to the Informed Consent Guidelines for details, directions, and examples of informed consent forms. Be sure to follow these guidelines carefully so that review of your research is not delayed: The majority of required revisions to applications concern the informed consent form. |
| Waiver or Alteration of Informed Consent | Federal Regulations allow an IRB to waive the requirement to obtain written documentation informed consent under certain circumstances. It is the responsibility of each research to request waivers or alterations in the protocol (under Section P: Plans for Obtaining and Documenting Informed Consent), and to ensure that the rights and welfare of participants are adequately protected. Researchers should indicate what conditions are being met that will allow for a waiver or alteration and indicate which elements are being waived or altered. |
| Part A -- 45 CFR 46.116(c) and (d) | The Common Rule permits an IRB to approve the conduct of research without meeting all of the required elements of informed consent.
Requests to waive or alter the consent process may be granted under the following conditions:
Government Program Evaluations
|
| Part B -- 45 CFR 46.117: Waiving Documentation of Informed Consent | Informed consent pertains to a process. It is possible to obtain informed consent without documenting the process,
and is advisable in some settings. Waiver of documentation is not the same as waiver of informed consent requirements.
Requests to waive the requirement to obtain a signed consent form may be granted when:
The consent form is the only record linking the subject and the research, and the principal risk to the participant would be
potential harm resulting fro a breach of confidentiality. Participants will be asked if they want documentation linking them to the research, and the
subject's wishes shall govern.
|
| Information Sheets | In cases where documentation of consent is waived, the IRB may require investigators to provide subjects with a written statement regarding the research called an Information Sheet. Most often, the information sheet is tailored very similarly to the Informed Consent Form without asking subjects to sign to document their consent. Therefore, if you would like to use an information sheet, please use the Informed Consent Guidelines to write this document. |
| Children | If children (>18) will be involved in research, the provisions for informed consent listed in Subpart D of the regulations must be followed. In general terms, these regulations require documented parental consent and child assent. |
- children
- prisoners
- pregnant women, fetuses, and neonates
- mentally disabled persons
- economically or educationally disadvantaged persons.
- inclusion and exclusion criteria for selecting and recruiting participants
- informed consent and voluntarism
- coercion and undue influence
- confidentiality of data
- group characteristics such as economic, social, physical, and environmental conditions, so that the research incorporates additional safeguards for vulnerable subjects.
- not over-selecting or excluding certain groups based on perceived limitations or complexities associated with those groups. For example, it is not appropriate to target prisoners as research subjects merely because they are a readily available "captive" population.
- knowledge about applicable laws that bear on the decision-making abilities of potentially vulnerable populations.
- Having adequate procedures in place for assessing subjects' capacity, understanding, and informed consent or assent. When weighing the decision whether to approve or disapprove research involving vulnerable subjects, the IRB will look to see that such procedures are a part of the research plan.
